Disclosure of industry payments to prescribers: industry payments might be a factor impacting generic drug prescribing.
Jingjing QianRichard A HansenDaniel SurryJennifer HowardZippora KiptanuiIlene HarrisPublished in: Pharmacoepidemiology and drug safety (2017)
Receipt of industry payments was associated with a decreased rate of generic drug prescribing. How this affects patient care and total medical costs warrants further study. Copyright © 2017 John Wiley & Sons, Ltd.